Phone
022 6663 8000
FAX
022 6663 8120
Email
info@bluecrosslabs.com
Contact Us

MEFTAL® – MR Tablets

COMPOSITION
MEFTAL – MR Tablets
Each Uncoated Tablet Contains:
Mefenamic acid IP 500 mg
Tizanidine HCl IP equivalent to Tizanidine 2 mg
INDICATIONS
MEFTAL-MR is indicated for short-term treatment of acute musculoskeletal disorders such as low backache, sprains, strains, sciatica, lumbago, torticollis occurring in adults.
DOSAGE AND ADMINISTRATION
Oral: The usual dose of MEFTAL-MR is one tablet to be taken three times daily with adequate amounts of water, preferably after food or snacks. The treatment lasts for 4-5 days. The drug is not to be continued for longer than seven days.
HOW SUPPLIED
10 Tablets per strip.